在此次获批之前，本公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一)已分别取得欧洲合格认证 ("CE")、美国食品药品监督管理局(Food and Drug Administration)("FDA")认证及澳大利亚药品管理局 (Therapeutic Goods Administration)("TGA")认证。该产品之核心技术来源于悉尼体外受精中心。结合Geri 湿式时差培养箱与AI胚胎评估系统，Geri胚胎培养液已正式进入中国临床实践，以其抗氧化配方与稳定 渗透压环境的两大核心优势，解决了高龄患者胚胎培养的难题。 Geri胚胎培养液的技术核心在于针对高龄患者生育难点构建系统性解决方案。其"三重抗氧化防护网"能 有效应对高龄胚胎的氧化应激难题，配合提前添加人血清白蛋白与超长效期稳定性，大幅简化实验室操 作并确保培养环境稳定。国际临床验证显示，该培养液结合Geri湿式时差培养箱及AI胚胎评估系统，可 显着提升优质囊胚率与临床妊娠率，为高龄生育提供坚实保障。 贝康医疗-B(02170)发布公告，本公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一)于2026年2月25 日获得中国国家药品监督管理 ...

Geri胚胎培养液的技术核心在于针对高龄患者生育难点构建系统性解决方案。其"三重抗氧化防护网"能 有效应对高龄胚胎的氧化应激难题，配合提前添加人血清白蛋白与超长效期稳定性，大幅简化实验室操 作并确保培养环境稳定。国际临床验证显示，该培养液结合Geri湿式时差培养箱及AI胚胎评估系统，可 显著提升优质囊胚率与临床妊娠率，为高龄生育提供坚实保障。 此次获批标志着公司实现从引进技术到本土化生产的关键跨越，填补国产高端辅助生殖耗材空白，成为 首个拥有FDA、CE、TGA、NMPA四大国际权威认证的中国企业。凭藉PGT核心技术及耗材自供能 力，公司已覆盖全国绝大部分PGT持牌机构，并设有数十家本地化实验室，形成持续迭代的生态壁垒。 格隆汇2月26日丨贝康医疗-B(02170.HK)公告，公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一) 于2026年2月25日获得中国国家药品监督管理局("国家药监局")颁发的三类医疗器械注册证(注册证号： 国械注进20263180071)。 在此次获批前，公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一)已分别取得欧洲合格认证 ("CE")、美国食品药品监督管理局(Fo ...

Major Events - Xinhua Wenhui (00811) signed a procurement contract with Sichuan Provincial Student Financial Aid Management Center worth approximately 1.264 billion [1] - Shandong Xinhua Pharmaceutical (00719) received the drug registration certificate for Minoxidil topical solution [1] - New天绿色能源 (00956) plans to fully acquire two wind energy companies in Chongli and Zhangbei to expand scale and improve management efficiency [1] - China Petroleum (00857) intends to acquire three gas storage facilities for 40.016 billion, significantly enhancing natural gas peak shaving capacity [1] - China Carbon Neutral (01372) and BRICS Capital jointly established a global carbon asset investment management company [1] Financial Performance - Zai Ding Pharmaceutical (09688) reported mid-term revenue of 216 million, a year-on-year increase of 15.35% [1] - Yadea Holdings (01585) reported mid-term profit attributable to shareholders of 1.649 billion, a year-on-year increase of 59.5% [1] - China National Pharmaceutical (03320) reported mid-term profit attributable to shareholders of 2.077 billion, a year-on-year decrease of 20.25% [1] - China Food (00506) reported mid-term profit attributable to shareholders of 578 million, a year-on-year increase of 2.23% [1] - CNOOC Services (02883) reported mid-term profit attributable to shareholders of 1.964 billion, a year-on-year increase of 23.33% [1] - China Petroleum (00857) reported mid-term net profit attributable to shareholders of 84.007 billion, a year-on-year decrease of 5.4% [1] - Nongfu Spring (09633) reported mid-term profit attributable to shareholders of 7.622 billion, a year-on-year increase of 22.16% [1] - Ping An Insurance (02318) reported mid-year operating profit of 77.732 billion, a year-on-year increase of 3.7% [1] - Beike-W (02423) reported mid-term net profit attributable to shareholders of 2.157 billion, a year-on-year decrease of 7.2% [1] - New天绿色能源 (00956) reported mid-term net profit attributable to shareholders of 1.412 billion, a year-on-year decrease of 1.23% [2] - China Duty Free (01880) reported mid-term profit attributable to shareholders of approximately 2.622 billion, a year-on-year decrease of 20.68% [2] - Conch Cement (00914) reported mid-term net profit attributable to shareholders of 4.368 billion, a year-on-year increase of 31.34% [2] - Zijin Mining (02899) reported mid-term net profit attributable to shareholders of 23.292 billion, a year-on-year increase of 54.41% [2] - China Foreign Transport (00598) reported mid-term net profit excluding non-recurring items of 1.398 billion, a year-on-year decrease of 22.30% [2] - Ansteel (00347) reported mid-term net loss of approximately 1.144 billion, a year-on-year reduction of 57.46% [2] - Chongqing Rural Commercial Bank (03618) reported mid-term net profit attributable to shareholders of 7.699 billion, a year-on-year increase of 4.63% [2] - Qingdao Beer (00168) reported mid-term net profit of approximately 3.904 billion, a year-on-year increase of 7.21% [2] - Sunac China (01918) reported mid-term loss attributable to shareholders of approximately 12.81 billion, a year-on-year decrease of about 14.4% [2]